ACCELERON PHARMA INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
ACCELERON PHARMA INC has filed 808 SEC EDGAR filings since 17 Feb 2004

SEC filing history

Showing 26-50 of 799 matching filings.

Per page
25
Current page
2
SC 14D9/A File 005-87630

ACCELERON PHARMA INC.

Filing date
10 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A File 005-87630

SC TO-T/A

Filing date
08 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9/A File 005-87630

SC 14D9/A

Filing date
08 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A File 005-87630

SC TO-T/A

Filing date
01 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9/A File 005-87630

SC 14D9/A

Filing date
01 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9 File 005-87630

ACCELERON PHARMA INC.

Filing date
28 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9 File 005-87630

ACCELERON PHARMA INC.

Filing date
20 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9 File 005-87630

ACCELERON PHARMA INC.

Filing date
13 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9 File 005-87630

SC 14D9

Filing date
12 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T File 005-87630

SC TO-T

Filing date
12 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-87630

ACCELERON PHARMA INC.

Filing date
05 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C File 005-87630

SC TO-C

Filing date
01 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C File 005-87630

SC TO-C

Filing date
30 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC14D9C File 005-87630

SC14D9C

Filing date
30 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC14D9C File 005-87630

ACCELERON PHARMA INC.

Filing date
30 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
27 Sep 2021
Reporting date
27 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
24 Sep 2021
Reporting date
23 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
22 Sep 2021
Reporting date
21 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
22 Sep 2021
Reporting date
21 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
09 Sep 2021
Reporting date
07 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .